The post Inveniam Capital Partners Acquires Storj to Advance Decentralized Data Infrastructure appeared on BitcoinEthereumNews.com. In a move that underscores the growing convergence of decentralized infrastructure and enterprise AI, Inveniam Capital Partners has signed a definitive agreement to acquire Storj, a long-time player in decentralized cloud storage, the company said in a press release Wednesday. Financial details of the transaction were not disclosed. The deal will fold Storj’s distributed storage and compute capabilities into Inveniam’s data operating and orchestration platform for private markets, the company said. Storj will continue operating as a standalone subsidiary, with no immediate changes to service contracts, pricing or leadership. “Storj’s unique technology is a critical enabler of Inveniam’s mission,” said Patrick O’Meara, chairman and CEO of Inveniam, in the release. “We’re particularly excited to integrate the STORJ token into our ecosystem, driving greater utility and alignment across our platforms,” he added. STORJ was 18% lower over the last 24 hours, trading around $0.18. Storj CEO Colby Winegar will continue to lead the subsidiary, and Executive Chair Ben Golub will join Inveniam’s board. The STORJ token will remain part of the platform, continuing to support Storj’s ecosystem. All customer, supplier, and community relationships, including those tied to its storage, GPU, and Petagene businesses, will remain in place, Inveniam said. Read more: Crypto-Backed Cloud-Storage Platform Storj Promotes Colby Winegar to CEO Source: https://www.coindesk.com/business/2025/10/22/inveniam-capital-partners-acquires-storj-to-advance-decentralized-data-infrastructureThe post Inveniam Capital Partners Acquires Storj to Advance Decentralized Data Infrastructure appeared on BitcoinEthereumNews.com. In a move that underscores the growing convergence of decentralized infrastructure and enterprise AI, Inveniam Capital Partners has signed a definitive agreement to acquire Storj, a long-time player in decentralized cloud storage, the company said in a press release Wednesday. Financial details of the transaction were not disclosed. The deal will fold Storj’s distributed storage and compute capabilities into Inveniam’s data operating and orchestration platform for private markets, the company said. Storj will continue operating as a standalone subsidiary, with no immediate changes to service contracts, pricing or leadership. “Storj’s unique technology is a critical enabler of Inveniam’s mission,” said Patrick O’Meara, chairman and CEO of Inveniam, in the release. “We’re particularly excited to integrate the STORJ token into our ecosystem, driving greater utility and alignment across our platforms,” he added. STORJ was 18% lower over the last 24 hours, trading around $0.18. Storj CEO Colby Winegar will continue to lead the subsidiary, and Executive Chair Ben Golub will join Inveniam’s board. The STORJ token will remain part of the platform, continuing to support Storj’s ecosystem. All customer, supplier, and community relationships, including those tied to its storage, GPU, and Petagene businesses, will remain in place, Inveniam said. Read more: Crypto-Backed Cloud-Storage Platform Storj Promotes Colby Winegar to CEO Source: https://www.coindesk.com/business/2025/10/22/inveniam-capital-partners-acquires-storj-to-advance-decentralized-data-infrastructure

Inveniam Capital Partners Acquires Storj to Advance Decentralized Data Infrastructure

In a move that underscores the growing convergence of decentralized infrastructure and enterprise AI, Inveniam Capital Partners has signed a definitive agreement to acquire Storj, a long-time player in decentralized cloud storage, the company said in a press release Wednesday.

Financial details of the transaction were not disclosed.

The deal will fold Storj’s distributed storage and compute capabilities into Inveniam’s data operating and orchestration platform for private markets, the company said.

Storj will continue operating as a standalone subsidiary, with no immediate changes to service contracts, pricing or leadership.

“Storj’s unique technology is a critical enabler of Inveniam’s mission,” said Patrick O’Meara, chairman and CEO of Inveniam, in the release.

“We’re particularly excited to integrate the STORJ token into our ecosystem, driving greater utility and alignment across our platforms,” he added.

STORJ was 18% lower over the last 24 hours, trading around $0.18.

Storj CEO Colby Winegar will continue to lead the subsidiary, and Executive Chair Ben Golub will join Inveniam’s board.

The STORJ token will remain part of the platform, continuing to support Storj’s ecosystem. All customer, supplier, and community relationships, including those tied to its storage, GPU, and Petagene businesses, will remain in place, Inveniam said.

Read more: Crypto-Backed Cloud-Storage Platform Storj Promotes Colby Winegar to CEO

Source: https://www.coindesk.com/business/2025/10/22/inveniam-capital-partners-acquires-storj-to-advance-decentralized-data-infrastructure

Market Opportunity
STORJ Logo
STORJ Price(STORJ)
$0.1286
$0.1286$0.1286
+0.39%
USD
STORJ (STORJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26